BR112022021066A2 - Corpo de planta do gênero nicotiana com baixo teor de alcaloide e método de produção do mesmo - Google Patents

Corpo de planta do gênero nicotiana com baixo teor de alcaloide e método de produção do mesmo

Info

Publication number
BR112022021066A2
BR112022021066A2 BR112022021066A BR112022021066A BR112022021066A2 BR 112022021066 A2 BR112022021066 A2 BR 112022021066A2 BR 112022021066 A BR112022021066 A BR 112022021066A BR 112022021066 A BR112022021066 A BR 112022021066A BR 112022021066 A2 BR112022021066 A2 BR 112022021066A2
Authority
BR
Brazil
Prior art keywords
plant
alkaloid content
production method
low alkaloid
genus nicotiana
Prior art date
Application number
BR112022021066A
Other languages
English (en)
Inventor
Takeuchi Takanori
Arai Masao
Udagawa Hisashi
Magome Hiroshi
Nishiguchi Ryo
Takakura Yoshimitsu
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of BR112022021066A2 publication Critical patent/BR112022021066A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
    • A01H1/10—Processes for modifying non-agronomic quality output traits, e.g. for industrial processing; Value added, non-agronomic traits
    • A01H1/101—Processes for modifying non-agronomic quality output traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine or caffeine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
    • A01H6/82—Solanaceae, e.g. pepper, tobacco, potato, tomato or eggplant
    • A01H6/823—Nicotiana, e.g. tobacco
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H5/00—Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
    • A01H5/12—Leaves
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0022—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C12Y104/03016—L-Aspartate oxidase (1.4.3.16)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Environmental Sciences (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Physiology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

CORPO DE PLANTA DO GÊNERO NICOTIANA COM BAIXO TEOR DE ALCALOIDE E MÉTODO DE PRODUÇÃO DO MESMO. Uma modalidade da presente invenção fornece uma planta de tabaco tendo um baixo teor de alcaloide. Na planta de tabaco, uma função de um gene que codifica a aspartato oxidase AO2 é suprimida.
BR112022021066A 2020-04-17 2021-04-19 Corpo de planta do gênero nicotiana com baixo teor de alcaloide e método de produção do mesmo BR112022021066A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020074233 2020-04-17
PCT/JP2021/015920 WO2021210688A1 (ja) 2020-04-17 2021-04-19 低アルカロイド含量のタバコ属植物体およびその製造方法

Publications (1)

Publication Number Publication Date
BR112022021066A2 true BR112022021066A2 (pt) 2022-12-06

Family

ID=78085131

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022021066A BR112022021066A2 (pt) 2020-04-17 2021-04-19 Corpo de planta do gênero nicotiana com baixo teor de alcaloide e método de produção do mesmo

Country Status (6)

Country Link
US (1) US20230120622A1 (pt)
EP (1) EP4136964A4 (pt)
JP (1) JP7210806B2 (pt)
CN (1) CN115485386B (pt)
BR (1) BR112022021066A2 (pt)
WO (1) WO2021210688A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115426874A (zh) * 2020-04-21 2022-12-02 日本烟草产业株式会社 烟草植物体及其制备方法
CN113528537A (zh) * 2021-08-11 2021-10-22 云南省烟草农业科学研究院 一种降低烟叶烟碱含量的NtQPT2基因突变体及其应用
WO2023127723A1 (ja) * 2021-12-27 2023-07-06 日本たばこ産業株式会社 タバコ植物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101672423B1 (ko) 2005-02-28 2016-11-03 22엔디 센츄리 리미티드, 엘엘씨 식물의 니코틴 알칼로이드 수준의 감소
WO2011102394A1 (ja) 2010-02-17 2011-08-25 日本たばこ産業株式会社 植物内容成分の調節因子、およびその利用
EP3140404A1 (en) * 2014-05-08 2017-03-15 Philip Morris Products S.A. Reduction of nicotine to nornicotine conversion in plants
AU2016362578B2 (en) * 2015-12-04 2022-08-04 North Carolina State University Targeted mutagenesis of tobacco berberine bridge enzyme-like nucleic acids
CN116058286A (zh) * 2016-03-30 2023-05-05 日本烟草产业株式会社 烟草植物体及其制备方法
US20180340180A1 (en) * 2017-05-19 2018-11-29 22Nd Century Limited, Llc Dominant-negative genetic manipulation to make low-nicotine tobacco products
US20200140875A1 (en) * 2017-05-31 2020-05-07 22Nd Century Limited, Llc Genome editing methods for producing low-nicotine tobacco products
WO2021113337A1 (en) * 2019-12-03 2021-06-10 Altria Client Services Llc Compositions and methods for producing tobacco plants and products having altered alkaloid levels
CN115927216A (zh) * 2021-08-10 2023-04-07 深圳瑞德林生物技术有限公司 一种s-尼古丁的制备方法

Also Published As

Publication number Publication date
EP4136964A4 (en) 2024-05-22
JPWO2021210688A1 (pt) 2021-10-21
CN115485386A (zh) 2022-12-16
WO2021210688A1 (ja) 2021-10-21
CN115485386B (zh) 2024-03-29
JP7210806B2 (ja) 2023-01-23
EP4136964A1 (en) 2023-02-22
US20230120622A1 (en) 2023-04-20

Similar Documents

Publication Publication Date Title
BR112022021066A2 (pt) Corpo de planta do gênero nicotiana com baixo teor de alcaloide e método de produção do mesmo
CR20220082A (es) N4-hidroxicitidina y derivados y usos antivirales relacionados con los mismos
BR112012008962A2 (pt) derivados espiro-condensados de ciclohexano como inibidores de hsl úteis para o tratamento de diabetes
BR112022017308A2 (pt) Composição que compreende lactoferrina e cepas bacterianas probióticas para uso oral com ação antiviral
BR112016001289A2 (pt) pancreatina de alta atividade (ha-pancreatina), composição farmacêutica de alta potência, processo para preparação da ha-pancreatina com atividade de lipase específica de, pelo menos, cerca de 120 ui usp/mg e método de tratamento de um paciente que apresenta uma condição fisiológica associada à insuficiência enzimática pancreática
BR112017024394A2 (pt) inibidores gata-3 para uso no tratamento da asma conduzida por th2
BR112013016837A2 (pt) método para melhorar a qualidade de uma planta
BR112021019262A2 (pt) Uso de ciclo-his-pro (chp) para prevenir, atenuar ou tratar fibrose
PT1423168E (pt) Composicao farmaceutica que compreende gabapentina ou um seu analogo e uma x-aminoamida e a sua utilizacao como analgesico
BR112023001792A2 (pt) Combinações para o tratamento de câncer
WO2022119858A8 (en) Compounds for the treatment of sars
CO2023004540A2 (es) Formas farmacéuticas sólidas de bacterias
EP4079301A3 (en) Compositions comprising cannabidiol and, optionally, bisabolol
MX2022004373A (es) Celulas madre modificadas y metodos de uso de las mismas.
BR112021016883A2 (pt) Composição contendo extrato derivado de planta e/ou produto processado derivado de planta
BR112014012966A2 (pt) método para o controle da proliferação de pseudomonas; e uso de um agente de desinfecção
BR112022015046A2 (pt) Uso de forsitina e/ou seus derivados, método para a inibição da proteína 3clpro do vírus covid-19, uso de composição de forsitina/forsitosídeo, métodos para uso contra o vírus covid-19 ou para o tratamento de doenças causadas pelo vírus covid-19, composição de forsitina/forsitosídeo e medicamento compreendendo uma composição de forsitina/forsitosídeo
BR112022020042A2 (pt) Método para tratar hiperinflamação com o uso de células-tronco ou precursoras de linhagem mesenquimal
BR112023020669A2 (pt) Terapias de combinação para o tratamento de câncer
BR112023016744A2 (pt) Métodos e composições que usam combinações de lactobacillus mucosae e fibra dietética solúvel
WO2022119854A8 (en) Compounds for the treatment of sars
MX2022012576A (es) Inhibidores de axl para terapia antiviral.
MX2022011475A (es) Azd1656 para el uso en el tratamiento de neumonitis y/o la miocarditis causadas por un coronavirus.
MX2022011138A (es) Efecto contra coronavirus y aplicacion de inhibidor de fosfatidilinositol 4-cinasa.
BR112022024005A2 (pt) Composição aquosa de fungicida ditiocarbamato

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.